Regulation FD Presentation (Form 8-K)
-2h 9m
Annual Report for Fiscal Year Ending April 30, 2025 (Form 10-K)
-2h 36m
Quarterly Report for Quarter Ending June 30, 2025 (Form 10-Q)
-2h 36m
FDA - Food and Drug Administration
-2h 36m
LEO Pharma Announces FDA Approval of ANZUPGO® (delgocitinib) Cream in the U.S.
-2h 55m
-3h 19m
Quarterly Report for Quarter Ending June 30, 2025 (Form 10-Q)
-3h 22m
ENDO 2025: PaTHway 3-Year Data
-3h 42m
-5h 33m
Skye’s 2025 Stockholder Letter ( SKYE 2025.04.25 Stockholder Letter )
-6h 36m